Cincinnati Eye Institute - Blue Ash

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Glaucoma1 trial
• High blood pressure1 trial
• Retinitis pigmentosa1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Laboratoires Thea1 trial
• NightstaRx Ltd, a Biogen Company1 trial

Closed trials

• Completed

  Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

  NCT05397600· Phase 3· Laboratoires Thea· Source

• Completed

  Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

  NCT03584165· Phase 3· NightstaRx Ltd, a Biogen Company· Source